How We Support Dealmaking

Locust Walk partners with biopharma companies as their strategic thought partner, leveraging our Co-founder Mentality. We put ourselves in our clients’ shoes to create the best positioning for their assets, creatively target logical and non-obvious buyers and assets, and support maximizing and optimizing the value of their programs. Everything we do is geared toward advancing innovation to market.
While we work on transactions, we are not transactional. We partner with companies in ways that other investment banks do not, delivering three main points of difference.

Deal Optionality to Maximize Value for Clients

We help find or create strategic partners to advance programs to patients.

Strategic Deals: Expertise in global and regional clinical and commercial asset partnering, company M&A, and pre-clinical and platform transactions.
NewCo Creation: We co-found NewCos with clients leveraging our capital
relationships, broad network of biopharma leaders, and strategic thinking to stand-
up new companies.

Local, On-The-Ground Teams Support Cross-Border Deals throughout US, Europe, and Asia

We are based in major biopharma hubs and deeply integrated into our local communities.

Presence in Key Markets: Boston, San Francisco, Tokyo, Shanghai, Beijing, and Suzhou.
Regional insights and connectivity, combined with local presence, support cross border dealmaking.

Science Forward, Strategic Dealmaking

Our entire deal team has a scientific background and/or operating experience in biopharma.
Strategic Positioning: Improve asset positioning for optimal partner engagement.
Deep Market Insights: Global and regional pharma and investor intelligence based on frequent, and actionable conversations with decisionmakers.